Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Clinical research Stories

2014-04-19 23:00:42

ReportsnReports.com adds the latest report on “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014” to its store. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=279869. Dallas, TX (PRWEB) April 19, 2014 This report provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Small Cell Lung Cancer. It includes an overview of the trial...

2014-04-18 23:08:24

OMICS Group announces the 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit during Sep 29 - Oct 01, 2014 at Baltimore, USA with the theme “Innovative Approaches of BABE to Revolutionize the Next Generation Medicine” Los Angeles, CA (PRWEB) April 18, 2014 BABE-2014 is all set to explore the innovations, advancements in the field of pharmaceutical industry, which shows significant impact on the development of new and improved generic drugs. These...

2014-04-18 23:04:04

Panel at DIA Annual Meeting to Explore Leveraging Data and Analytics to Enhance Collaboration Washington (PRWEB) April 18, 2014 The impact of “big data” on the partnerships between contract research organizations (CROs) and clinical trial sponsors will be discussed at the DIA 2014 50th Annual Meeting, June 15 to 19, in San Diego. The “Big Data, Big Impact: New Levels of Strategic Partnerships Between Sponsors-CROs” forum, held on June 17 at 8 a.m. in the San Diego Convention...

2014-04-18 23:02:27

The Firm is actively filing GranuFlo lawsuits on behalf of dialysis patients who allegedly experienced sudden cardiac death, strokes, heart attacks and other devastating heart problems within 72 hours of receiving the medication. New York, NY (PRWEB) April 18, 2014 Bernstein Liebhard LLP has launched a new website for dialysis patients and families who were allegedly affected by the GranuFlo recall (http://www.granuflolawsuit2014.com/) of June 2012, and are now considering a claim against...

2014-04-18 20:21:09

PITTSBURGH, April 18, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that Supreme Court Chief Justice Roberts has denied Teva's application for an injunction seeking to prevent Mylan's launch of a generic version of Copaxone(®) pending the Supreme Court's decision on Teva's appeal. This is the second time that the Chief Justice has denied Teva's request for such an injunction. In March, the Supreme Court granted Teva's petition for certiorari seeking clarification of...

2014-04-18 16:22:52

LOS ANGELES, April 18, 2014 /PRNewswire/ -- The Torkzadeh Law Firm (TorkLaw) is now representing over 100 clients against St. Jude Medical, Inc. related to the recalled St. Jude Medical, Inc. Riata leads. In November 2011, the FDA issued a Class 1 recall of the St. Jude Medical Riata and Riata ST Silicone Endocardial Defibrillation Leads. The FDA noted evidence that the silicone insulation covering the leads is at risk for premature abrasion and externalization. As a result of...

2014-04-17 23:14:05

On March 26, the FDA announced the recall of Bella Vi products by Pure Edge Nutrition because they contain undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 16, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for weight loss dietary supplements. As the FDA...

2014-04-17 23:05:28

Number of Lawsuits Pending Against Manufacturer Approaches 6,000 DALLAS (PRWEB) April 17, 2014 National law firm Baron & Budd reports that the number of lawsuits against the manufacturer of GranuFlo continues to increase. The lawsuits stem from patients who suffered adverse health effects after undergoing dialysis treatment where the product was used. Baron and Budd shareholders currently serve on the leadership committee, known as the Plaintiffs’ Steering Committee, in the...

2014-04-17 12:29:28

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Brain Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/brain_cancer_global_clinical_trials_review_h1_2014.htmlBrain Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Brain Cancer Global Clinical Trials Review, H1, 2014" provides data on the Brain Cancer clinical trial scenario. This report...

2014-04-17 00:21:10

DUBLIN, April 17, 2014 /PRNewswire/ -- Heart Metabolics Limited, a new Irish biotechnology company focused on development of drugs for cardio-metabolic diseases, has announced the completion of a $20 million Series A financing from venBio, Seroba Kernel Life Sciences, Brandon Capital Partners (on behalf of AustralianSuper) and AshHill. The proceeds from this financing have supported Heart Metabolics Limited in acquiring a Phase 3-ready drug candidate and related preclinical drug...